Global Intragastric Balloons Market to Reach US$50.7 Million by 2030
The global market for Intragastric Balloons estimated at US$25.3 Million in the year 2023, is expected to reach US$50.7 Million by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030. Single Intragastric Balloons, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$33.4 Million by the end of the analysis period. Growth in the Dual Intragastric Balloons segment is estimated at 11.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$6.6 Million While China is Forecast to Grow at 13.6% CAGR
The Intragastric Balloons market in the U.S. is estimated at US$6.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.6 Million by the year 2030 trailing a CAGR of 13.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.
Intragastric balloons are non-surgical, minimally invasive devices that are temporarily placed in the stomach to help individuals lose weight by reducing their food intake. These balloons are inserted endoscopically and filled with saline or gas, occupying space in the stomach and inducing a feeling of fullness, which helps patients eat smaller portions and lose weight more effectively. Intragastric balloons are gaining popularity in weight loss treatments due to their effectiveness, lower risk compared to bariatric surgery, and the increasing prevalence of obesity worldwide. They offer a reversible option for patients who may not qualify for, or prefer to avoid, more invasive surgical interventions, making them an attractive alternative for weight management.
Technological advancements are significantly shaping the intragastric balloons market, particularly through innovations in balloon design, materials, and deployment techniques. The development of newer-generation balloons that are more durable, adjustable, and easier to insert and remove has improved the safety and efficacy of this treatment. Some intragastric balloons are now designed to be swallowed in capsule form, eliminating the need for endoscopy and sedation, which makes the procedure less invasive and more appealing to a broader range of patients. Additionally, advancements in materials, such as the use of biocompatible and durable polymers, have enhanced the balloon’s ability to withstand the acidic environment of the stomach, reducing the risk of deflation and other complications. These technological innovations are driving the adoption of intragastric balloons as a viable option for weight loss, as they offer patients a safer and more convenient alternative to traditional surgical procedures.
The demand for intragastric balloons is increasing in weight management due to the rising prevalence of obesity, the growing awareness of non-surgical weight loss options, and the desire for less invasive treatments. As obesity rates continue to climb globally, more individuals are seeking effective weight loss solutions that do not involve the risks associated with bariatric surgery. Intragastric balloons are becoming a preferred option for patients who need to lose weight before undergoing other medical procedures or for those who want to avoid the long-term commitment of surgical interventions. The increasing availability of these devices in specialized weight loss clinics and the growing support from healthcare providers are also contributing to the market’s expansion. Additionally, the emphasis on preventive healthcare and the management of obesity-related comorbidities, such as diabetes and cardiovascular disease, is driving demand for intragastric balloons as an effective tool for achieving significant weight loss.
The growth in the intragastric balloons market is driven by several factors closely tied to technological advancements, the rising prevalence of obesity, and the increasing demand for non-surgical weight loss solutions. One of the primary drivers is the growing obesity epidemic, which has led to a surge in demand for effective weight management treatments that are less invasive than traditional bariatric surgery. Technological advancements in balloon design and materials have also played a significant role, making the procedure safer, more effective, and more accessible to a wider range of patients. The expanding network of specialized weight loss clinics and the increasing acceptance of intragastric balloons by healthcare providers are further propelling market growth. Additionally, the trend towards preventive healthcare and the focus on managing obesity-related health risks are driving demand for this minimally invasive treatment option. As these factors continue to shape the healthcare landscape, the intragastric balloons market is expected to experience sustained growth, driven by the need for effective, safe, and convenient weight loss solutions.
Select Competitors (Total 46 Featured) -Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook